| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $136.1M | +22.4% |
| Cost of Revenue | $84.3M | +64.6% |
| Gross Profit | $51.8M | -13.5% |
| R&D Expense | $85.0M | +53.5% |
| SG&A Expense | $242.3M | +59.0% |
| Operating Income | -$275.5M | -86.4% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$110.1M | +67.5% |
| Income Tax | $1.2M | +672.8% |
| Net Income | -$111.3M | +67.1% |
| EPS (Basic) | -$0.39 | +84.9% |
| EPS (Diluted) | -$0.39 | +84.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $117.1M | -16.0% |
| Accounts Receivable | $20.8M | +91.6% |
| Inventory | $11.1M | +97.8% |
| Current Assets | $517.9M | +18.3% |
| Total Assets | $640.4M | -11.0% |
| Current Liabilities | $49.0M | +47.0% |
| Total Liabilities | $56.5M | -87.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$118.6M | -205.5% |
| Capital Expenditures | $1.7M | +113.6% |
| Investing Cash Flow | $95.2M | +117.6% |
| Financing Cash Flow | $277K | -100.0% |
| Free Cash Flow | -$120.3M | -203.6% |
| Stockholders' Equity |
| $583.9M |
| +117.7% |